Lv3
262 积分 2022-12-02 加入
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
14小时前
已完结
Facilitating high throughput bispecific antibody production and potential applications within biopharmaceutical discovery workflows
2个月前
已完结
Engineering therapeutic bispecific antibodies using CrossMab technology
3个月前
已完结
Targeting Strategies for Tissue-Specific Drug Delivery
3个月前
已完结
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
4个月前
已完结
Nutrient-driven histone code determines exhausted CD8 + T cell fates
4个月前
已完结
SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
4个月前
已关闭
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
5个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
5个月前
已完结
The antibody–drug conjugate landscape
5个月前
已完结
皖公网安备34019202002308
